Pramipexole/ondansetron, also known by its developmental code name ALTO-207 and formerly as CTC-501, is a combination of pramipexole, a dopamine D2-like receptor agonist, and ondansetron, a serotonin 5-HT3 receptor antagonist, which is under development for treatment-resistant major depressive disorder (TRD or MDD).
The compounds of every Wikipedia article carrying a Chembox or a Drugbox, refreshed daily, with the values their infoboxes give. The pages need JavaScript; the API does not.